Fortress Biotech (FBIO) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free FBIO Stock Alerts $1.72 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Fortress Biotech Short Interest DataCurrent Short Volume1,820,000 sharesPrevious Short Volume1,880,000 sharesChange Vs. Previous Month-3.19%Dollar Volume Sold Short$3.31 millionShort Interest Ratio / Days to Cover6.1Last Record DateApril 15, 2024Outstanding Shares19,240,000 sharesFloat Size13,980,000 sharesShort Percent of Float13.02%Today's Trading Volume104,621 sharesAverage Trading Volume390,863 sharesToday's Volume Vs. Average27% Short Selling Fortress Biotech ? Sign up to receive the latest short interest report for Fortress Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFBIO Short Interest Over TimeFBIO Days to Cover Over TimeFBIO Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Fortress Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,820,000 shares $3.31 million -3.2%13.0%6.1 $1.82 3/31/20241,880,000 shares $3.76 million +8.7%14.1%4.8 $2.00 3/15/20241,730,000 shares $3.35 million +12.3%13.0%3.5 $1.94 2/29/20241,540,000 shares $3.20 million -6.1%11.5%2.8 $2.08 2/15/20241,640,000 shares $3.08 million +10.1%12.3%2.8 $1.88 1/31/20241,490,000 shares $3.04 million +15.5%12.3%1.8 $2.04 Get the Latest News and Ratings for FBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,290,000 shares $2.48 million +14.2%10.6%1.6 $1.92 12/31/20231,130,000 shares $3.40 million +24.5%9.3%1.5 $3.01 12/15/2023907,400 shares $2.79 million +46.8%8.8%1.6 $3.07 11/30/2023618,000 shares $1.22 million +137.9%8.3%1.3 $1.98 11/15/2023259,800 shares $358,524.00 +52.9%3.5%0.7 $1.38 10/31/2023169,900 shares $304,121.00 +85.5%2.8%3 $1.79 10/15/202391,600 shares $265,640.00 +102.2%1.5%2 $2.90 9/30/202345,300 shares $197,258.85 -93.7%0.7%1.1 $4.35 9/15/2023715,100 shares $250,285.00 +0.6%0.8%1.2 $0.35 8/31/2023710,900 shares $248,815.00 +24.1%0.8%1.1 $0.35 8/15/2023572,800 shares $294,190.08 -15.2%0.6%0.9 $0.51 7/31/2023675,700 shares $385,149.00 +10.2%0.7%0.9 $0.57 7/15/2023613,200 shares $315,798.00 +13.5%0.7%0.9 $0.52 6/30/2023540,400 shares $297,220.00 +13.0%0.6%0.9 $0.55 6/15/2023478,400 shares $325,312.00 -44.8%0.5%0.8 $0.68 5/31/2023865,900 shares $465,854.20 +23.2%1.0%1.5 $0.54 5/15/2023702,900 shares $496,950.30 +6.8%0.8%1 $0.71 4/30/2023658,400 shares $504,992.80 -36.7%0.8%1.1 $0.77 4/15/20231,040,000 shares $842,296.00 -8.0%1.3%1.7 $0.81 3/31/20231,130,000 shares $926,600.00 +14.2%1.7%1.8 $0.82 3/15/2023989,200 shares $713,905.64 +200.9%1.4%1.4 $0.72 2/28/2023328,800 shares $253,176.00 -22.1%0.5%0.5 $0.77 2/15/2023422,000 shares $313,335.00 -3.7%0.7%0.8 $0.74 1/31/2023438,100 shares $398,671.00 +11.9%0.6%1 $0.91 1/15/2023391,700 shares $345,401.06 -51.3%0.5%1 $0.88 12/30/2022804,100 shares $526,685.50 +9.1%1.0%2.5 $0.66 12/15/2022737,400 shares $443,103.66 +10.9%0.9%3.5 $0.60 11/30/2022664,700 shares $439,566.11 +5.1%0.8%3.4 $0.66 11/15/2022632,600 shares $556,688.00 +4.5%0.8%3.6 $0.88 10/31/2022605,200 shares $502,376.52 +2.3%0.8%3.2 $0.83 10/15/2022591,400 shares $456,619.94 -20.9%0.7%2.6 $0.77 9/30/2022747,200 shares $642,592.00 +19.9%0.8%3.2 $0.86 9/15/2022623,400 shares $642,102.00 +0.1%0.7%1.3 $1.03 8/31/2022622,800 shares $635,256.00 -7.3%0.7%1.2 $1.02These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy FBIO Short Interest - Frequently Asked Questions What is Fortress Biotech's current short interest? Short interest is the volume of Fortress Biotech shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,820,000 shares of FBIO short. 13.02% of Fortress Biotech's shares are currently sold short. Learn More on Fortress Biotech's current short interest. What is a good short interest ratio for Fortress Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBIO shares currently have a short interest ratio of 6.0. Learn More on Fortress Biotech's short interest ratio. Which institutional investors are shorting Fortress Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fortress Biotech: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fortress Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.02% of Fortress Biotech's floating shares are currently sold short. Is Fortress Biotech's short interest increasing or decreasing? Fortress Biotech saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,820,000 shares, a decline of 3.2% from the previous total of 1,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fortress Biotech's float size? Fortress Biotech currently has issued a total of 19,240,000 shares. Some of Fortress Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fortress Biotech currently has a public float of 13,980,000 shares. How does Fortress Biotech's short interest compare to its competitors? 13.02% of Fortress Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Fortress Biotech: Bolt Biotherapeutics, Inc. (8.63%), Chimerix, Inc. (1.66%), Emergent BioSolutions Inc. (11.76%), Xilio Therapeutics, Inc. (4.35%), Viracta Therapeutics, Inc. (2.50%), VYNE Therapeutics Inc. (0.80%), BriaCell Therapeutics Corp. (4.88%), CASI Pharmaceuticals, Inc. (0.99%), Unicycive Therapeutics, Inc. (1.53%), Theratechnologies Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Fortress Biotech stock? Short selling FBIO is an investing strategy that aims to generate trading profit from Fortress Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fortress Biotech? A short squeeze for Fortress Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBIO, which in turn drives the price of the stock up even further. How often is Fortress Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BOLT Short Interest Data CMRX Short Interest Data EBS Short Interest Data XLO Short Interest Data VIRX Short Interest Data VYNE Short Interest Data BCTX Short Interest Data CASI Short Interest Data UNCY Short Interest Data THTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FBIO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry